Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models
Preexposure prophylaxis (PrEP) with tenofovir and emtricitabine can prevent new HIV-1 infections, but there is a concern that use of PrEP could increase HIV drug resistance resulting in loss of treatment options. We compared standardized outcomes from three independent mathematical models simulating...
Hauptverfasser: | van de Vijver, DAMC, Nichols, BE, Abbas, UL, Boucher, CAB, Cambiano, V, Eaton, JW, Glaubius, R, Katrina Lythgoe, Mellors, J, Phillips, A, Sigaloff, KC, Hallett, TB |
---|---|
Format: | Journal article |
Sprache: | English |
Veröffentlicht: |
Lippincott, Williams and Wilkins
2013
|
Ähnliche Einträge
Ähnliche Einträge
-
AIDS vaccines and preexposure prophylaxis: is synergy possible?
von: Excler, J, et al.
Veröffentlicht: (2011) -
Clinical Considerations in the Selection of Preexposure Prophylaxis for HIV Prevention in Canada
von: David C. Knox, et al.
Veröffentlicht: (2022-01-01) -
HIV Risk and Interest in Preexposure Prophylaxis in Justice-Involved Persons
von: Ank E. Nijhawan, et al.
Veröffentlicht: (2024-04-01) -
HIV preexposure prophylaxis and postexposure prophylaxis in women: a comprehensive guide for healthcare providers
von: Niam Vora, et al.
Veröffentlicht: (2024-12-01) -
HIV Care Continuum and Preexposure Prophylaxis Program in Federal Bureau of Prisons, United States
von: Xiao Hong Huang, et al.
Veröffentlicht: (2024-04-01)